Transforming growth factor-β2 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells

American Journal of Physiology - Renal Physiology

Volumn 291, Issue 5, 2006, Pages

  Qi, Weier ^a   Chen, Xinming ^a   Holian, John ^a   Mreich, Ellein ^a   Twigg, Stephen ^b   Gilbert, Richard E ^c,d   Pollock, Carol A ^a,e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Activator protein 1; Chemokine; Nuclear factor B; pSmad; Small interference RNA

Indexed keywords

CYTOKINE; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; CCL2 PROTEIN, HUMAN; SMAD2 PROTEIN; SMAD2 PROTEIN, HUMAN; TGFB1 PROTEIN, HUMAN; TGFB2 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CONTROLLED STUDY; DNA BINDING; EXTRACELLULAR MATRIX; FIBROGENESIS; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; CELL LINE; CYTOLOGY; GENETICS; METABOLISM; SECRETION;

CELL LINE, TRANSFORMED; CHEMOKINE CCL2; FIBRONECTINS; HUMANS; INTERLEUKIN-8; KIDNEY TUBULES, PROXIMAL; NF-KAPPA B; RNA, MESSENGER; RNA, SMALL INTERFERING; SMAD2 PROTEIN; TRANSCRIPTION FACTOR AP-1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

EID: 33750938708     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00013.2006     Document Type: Article

References (43)

1. Bian ZM, Elner SG, Yoshida A, and Elner VM. Differential involvement of phosphoinositide 3-kinase/Akt in human RPE MCP-1 and IL-8 expression. Invest Ophthalmol Vis Sci 45: 1887-1896, 2004.
2. Bottinger EP, Letterio JJ, and Roberts AB. Biology of TGF-beta in knockout and transgenic mouse models. Kidney Int 51: 1355-1360, 1997.
3. Brat DJ, Bellail AC, and Van Meir EG. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro-oncol 7: 122-133, 2005.
4. Campos-Xavier B, Saraiva JM, Savarirayan R, Verloes A, Feingold J, Faivre L, Munnich A, Le Merrer M, and Cormier-Daire V. Phenotypic variability at the TGF-beta1 locus in Camurati-Engelmann disease. Hum Genet 109: 653-658, 2001.
5. Chaturvedi K and Sarkar DK. Role of protein kinase C-Ras-MAPK p44/42 in ethanol and transforming growth factor-beta3-induced basic fibroblast growth factor release from folliculostellate cells. J Pharmacol Exp Ther 314: 1346-1352, 2005.
6. Chen S, Hoffman BB, Lee JS, Kasama Y, Jim B, Kopp JB, and Ziyadeh FN. Cultured tubule cells from TGF-beta1 null mice exhibit impaired hypertrophy and fibronectin expression in high glucose. Kidney Int 65: 1191-1204, 2004.
7. Chen S, Mukherjee S, Chakraborty C, and Chakrabarti S. High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-κB and AP-1. Am J Physiol Cell Physiol 284: C263-C272, 2003.
8. Cui XM, Chai Y, Chen J, Yamamoto T, Ito Y, Bringas P, and Shuler CF. TGF-beta3-dependent SMAD2 phosphorylation and inhibition of MEE proliferation during palatal fusion. Dev Dyn 227: 387-394, 2003.
9. Dhandapani KM, Hadman M, De Sevilla L, Wade MF, Mahesh VB, and Brann DW. Astrocyte protection of neurons: role of transforming growth factor-beta signaling via a c-Jun-AP-1 protective pathway. J Biol Chem 278: 43329-43339, 2003.
10. Fuchshofer R, Birke M, Welge-Lussen U, Kook D, and Lutjen-Drecoll E. Transforming growth factor-beta 2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes. Invest Ophthalmol Vis Sci 46: 568-578, 2005.
11. Hartner A, Hilgers KF, Bitzer M, Veelken R, and Schocklmann HO. Dynamic expression patterns of transforming growth factor-beta2 and transforming growth factor-beta receptors in experimental glomerulonephritis. J Mol Med 81: 32-42, 2003.
12. Hill C, Flyvbjerg A, Gronbaek H, Petrik J, Hill DJ, Thomas CR, Sheppard MC, and Logan A. The renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats. Endocrinology 141: 1196-1208, 2000.
13. Hill C, Flyvbjerg A, Rasch R, Bak M, and Logan A. Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney. J Endocrinol 170: 647-651, 2001.
14. Janssens K, Gershoni-Baruch R, Guanabens N, Migone N, Ralston S, Bonduelle M, Lissens W, Van Maldergem L, Vanhoenacker F, Verbruggen L, and Van Hul W. Mutations in the gene encoding the latency-associated peptide of TGF-beta 1 cause Camurati-Engelmann disease. Nat Genet 26: 273-275, 2000.
15. Kaltschmidt B and Kaltschmidt C. DNA array analysis of the developing rat cerebellum: transforming growth factor-beta2 inhibits constitutively activated NF-kappaB in granule neurons. Mech Dev 101: 11-19, 2001.
16. Kinoshita A, Saito T, Tomita H, Makita Y, Yoshida K, Ghadami M, Yamada K, Kondo S, Ikegawa S, Nishimura G, Fukushima Y, Nakagomi T, Saito H, Sugimoto T, Kamegaya M, Hisa K, Murray JC, Taniguchi N, Niikawa N, and Yoshiura K. Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease. Nat Genet 26: 19-20, 2000.
17. Komura E, Tonetti C, Penard-Lacronique V, Chagraoui H, Lacout C, Lecouedic JP, Rameau P, Debili N, Vainchenker W, and Giraudier S. Role for the nuclear factor kappaB pathway in transforming growth factor-beta1 production in idiopathic myelofibrosis: possible relationship with FK506 binding protein 51 overexpression. Cancer Res 65: 3281-3289, 2005.
18. Konig HG, Kogel D, Rami A, and Prehn JH. TGF-beta1 activates two distinct type I receptors in neurons: implications for neuronal NF-kappaB signaling. J Cell Biol 168: 1077-1086, 2005.
19. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, and Karlsson S. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90: 770-774, 1993.
20. Kwon D, Fuller AC, Palma JP, Choi IH, and Kim BS. Induction of chemokines in human astrocytes by picornavirus infection requires activation of both AP-1 and NF-kappa B. Glia 45: 287-296, 2004.
21. Lee BH, Park SY, Kang KB, Park RW, and Kim IS. NF-kappaB activates fibronectin gene expression in rat hepatocytes. Biochem Biophys Res Commun 297: 1218-1224, 2002.
22. Lu T, Burdelya LG, Swiatkowski SM, Boiko AD, Howe PH, Stark GR, and Gudkov AV. Secreted transforming growth factor beta2 activates NF-kappaB, blocks apoptosis, and is essential for the survival of some tumor cells. Proc Natl Acad Sci USA 101: 7112-7117, 2004.
23. Molin DG, Poelmann RE, DeRuiter MC, Azhar M, Doetschman T, and Gittenberger-de Groot AC. Transforming growth factor beta-SMAD2 signaling regulates aortic arch innervation and development. Circ Res 95: 1109-1117, 2004.
24. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, Rifkin DB, and Sheppard D. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328, 1999.
25. Panchapakesan U, Sumual S, Pollock CA, and Chen X. PPARγ agonists exert antifibrotic effects in renal tubular cells exposed to high glucose. Am J Physiol Renal Physiol 289: F1153-F1158, 2005.
26. Papakonstantinou E, Aletras AJ, Roth M, Tamm M, and Karakiulakis G. Hypoxia modulates the effects of transforming growth factor-beta isoforms on matrix-formation by primary human lung fibroblasts. Cytokine 24: 25-35, 2003.
27. 1 induces IL-8 and MCP-1 through a connective tissue growth factor-independent pathway. Am J Physiol Renal Physiol 290: F703-F709, 2006.
28. Saika S, Yamanaka O, Ikeda K, Kim-Mitsuyama S, Flanders KC, Yoo J, Roberts AB, Nishikawa-Ishida I, Ohnishi Y, Muragaki Y, and Ooshima A. Inhibition of p38MAP kinase suppresses fibrotic reaction of retinal pigment epithelial cells. Lab Invest 85: 838-850, 2005.
29. Saito T, Kinoshita A, Yoshiura K, Makita Y, Wakui K, Honke K, Niikawa N, and Taniguchi N. Domain-specific mutations of a transforming growth factor (TGF)-beta 1 latency-associated peptide cause Camurati-Engelmann disease because of the formation of a constitutively active form of TGF-beta 1. J Biol Chem 276: 11469-11472, 2001.
30. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, Cardell EL, and Doetschman T. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124: 2659-2670, 1997.
31. Schnaper HW, Hayashida T, and Poncelet AC. It's a Smad world: regulation of TGF-beta signaling in the kidney. J Am Soc Nephrol 13: 1126-1128, 2002.
32. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, and Doetschman T. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693-699, 1992.
33. Tamura K, Nyui N, Tamura N, Fujita T, Kihara M, Toya Y, Takasaki I, Takagi N, Ishii M, Oda K, Horiuchi M, and Umemura S. Mechanism of angiotensin II-mediated regulation of fibronectin gene in rat vascular smooth muscle cells. J Biol Chem 273: 26487-26496, 1998.
34. Tchilibon S, Zhang J, Yang Q, Eidelman O, Kim H, Caohuy H, Jacobson KA, Pollard BS, and Pollard HB. Amphiphilic pyridinium salts block TNF alpha/NF kappa B signaling and constitutive hypersecretion of interleukin-8 (IL-8) from cystic fibrosis lung epithelial cells. Biochem Pharmacol 70: 381-393, 2005.
35. Tseng L, Tang M, Wang Z, and Mazella J. Progesterone receptor (hPR) upregulates the fibronectin promoter activity in human decidual fibroblasts. DNA Cell Biol 22: 633-640, 2003.
36. Wang W, Huang XR, Li AG, Liu F, Li JH, Truong LD, Wang XJ, and Lan HY. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7. J Am Soc Nephrol 16: 1371-1383, 2005.
37. Weigert C, Brodbeck K, Brosius FC III, Huber M, Lehmann R, Friess U, Facchin S, Aulwurm S, Haring HU, Schleicher ED, and Heilig CW. Evidence for a novel TGF-beta1-independent mechanism of fibronectin production in mesangial cells overexpressing glucose transporters. Diabetes 52: 527-535, 2003.
38. Wen FQ, Kohyama T, Skold CM, Zhu YK, Liu X, Romberger DJ, Stoner J, and Rennard SI. Glucocorticoids modulate TGF-beta production by human fetal lung fibroblasts. Inflammation 27: 9-19, 2003.
39. Wilson HM, Minto AW, Brown PA, Erwig LP, and Rees AJ. Transforming growth factor-beta isoforms and glomerular injury in nephrotoxic nephritis. Kidney Int 57: 2434-2444, 2000.
40. Xiao YQ, Malcolm K, Worthen GS, Gardai S, Schiemann WP, Fadok VA, Bratton DL, and Henson PM. Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-beta. J Biol Chem 277: 14884-14893, 2002.
41. Yamada M, Kim S, Egashira K, Takeya M, Ikeda T, Mimura O, and Iwao H. Molecular mechanism and role of endothelial monocyte chemoattractant protein-1 induction by vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 23: 1996-2001, 2003.
42. Yu L, Border WA, Huang Y, and Noble NA. TGF-beta isoforms in renal fibrogenesis. Kidney Int 64: 844-856, 2003.
43. Yue J and Mulder KM. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a smad-dependent pathway. J Biol Chem 275: 35656, 2000.